Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II N=1 randomized double-blind repeated crossover pilot study of simvastatin for L-dopa–induced dyskinesia in Parkinson's disease
2009-011736-35Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) and levodopa-induced dyskinesia (LID) comparing Sequence starting with simvastatin add-on with Sequence starting with placebo add-on (2 arms). Primary endpoint: Subjective dyskinesia discomfort score over the preceding week. Started Aug 2009; status: active.
02
Drugs
simvastatin
03
Conditions
Parkinson's disease (PD)levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on 2009-011736-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011736-35.